Oct 30, 2014 at 17:05 | Source: CNBC-TV18
Commenting the markets move, Raamdeo Agrawal, joint managing director, Motilal Oswal, said the recent selling for foreign investors had abated and this had pushed markets higher and that one was likely to see fresh highs ahead.
Oct 30, 2014 at 09:11 | Source: CNBC-TV18
Dipan Mehta, member BSE and NSE says by and large tech and pharma companies have disappointed this earnings season.
Oct 29, 2014 at 11:19 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com advises buying Ranbaxy Laboratories at current levels.
Oct 29, 2014 at 10:58 | Source: CNBC-TV18
Prakash Agarwal, Equity Analyst at CIMB is of the view that one may hold Sun Pharmaceutical Industries.
Oct 29, 2014 at 09:43 | Source: CNBC-TV18
According to Prakash Agarwal, Equity Analyst at CIMB, one may hold Ranbaxy Laboratories.
Oct 29, 2014 at 09:05 | Source: CNBC-TV18
Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share.
Oct 29, 2014 at 08:36 | Source: CNBC-TV18
Here are Top 10 stocks to focus on October 29 - HDFC, Crompton Greaves, ING Vysya, Jubilant Life, Nestle, Ranbaxy, PI Industries, CCL Prod, SRF, VST Industries.
Oct 29, 2014 at 08:28 | Source: CNBC-TV18
Hero Motocorp | State Bank of India | Dr Reddy's Labs | ONGC | BHEL | Ranbaxy Labs | Jubilant Life | ING Vysya Bank | SRF | CCL Products | PI Industries | Nestle India | IL&FS Engineering | State Bank of Travancore and State Bank of Bikaner and Jaipur are stocks, which are in the news today.
Oct 28, 2014 at 15:59 | Source: CNBC-TV18
Ranbaxy Laboratories has turned profitable in the second quarter of current financial year. The company reported consolidated net profit of Rs 478 crore during the quarter as against loss of Rs 454 crore in the year-ago period.
Oct 28, 2014 at 15:03 | Source: CNBC-TV18
Yogesh Mehta of Motilal Oswal Securities is of the view that Cipla may touch Rs 685-690.